Latest Articles

Publication Date
Self-Reported Adolescent Menstrual Symptoms and Delayed Gynecologic Consultation among Japanese Women with Endometriosis.

Endometriosis symptoms often first appear during adolescence, yet delays in seeking gynecologic consultation remain a persistent challenge worldwide. Despite growing international evidence, the specific patterns of symptom recognition and consultation …

Published: July 1, 2026, midnight
Tokishakuyakusan suppresses endometriosis and may be associated with improved fertility during attempts to conceive: A mouse model study.

Tokishakuyakusan (TSS), a traditional Japanese Kampo medicine, is known for its anti-inflammatory and anti-angiogenic properties. This study examined the effects of TSS on fecundity and endometriosis-like lesions during pregnancy in …

Published: June 30, 2026, midnight
Association between menstrual-related disorders and sexually transmitted infections: A nationwide cross-sectional study in Japan.

To investigate the association between menstrual-related disorders and sexually transmitted infections (STI) among young women in Japan, and to examine differences according to disorder type and hormonal therapy use.

Published: June 16, 2026, midnight
Cartherics secures Japanese patent to bolster cell therapy push - Biotech Dispatch

Cartherics secures Japanese patent to bolster cell therapy push Biotech Dispatch

Published: June 11, 2026, 1:50 a.m.
Cartherics secures Japanese patent to bolster cell therapy push - PharmaDispatch

Cartherics secures Japanese patent to bolster cell therapy push PharmaDispatch

Published: June 10, 2026, 12:17 a.m.
Uterine and Sigmoid Colon Perforation Following Hysteroscopy-Guided Microwave Endometrial Ablation (MEA) in a Patient With a Bicornuate Uterus and Multiple Myomas: A Case Report.

In Japan, the microwave endometrial ablation system (MEA, Microsulis PLC, Waterlooville, UK) is the most widely used device for endometrial ablation and is considered a minimally invasive, uterus-preserving treatment for …

Published: April 29, 2026, midnight
LG Chem Licenses Japan's Top Endometriosis Drug to Expand Women's Health Business - Seoul Economic Daily

LG Chem Licenses Japan's Top Endometriosis Drug to Expand Women's Health Business Seoul Economic Daily

Published: April 3, 2026, 2:09 a.m.
LG Chem Introduces Endometriosis Treatment 'Dinagest' from Japan's Mochida Pharmaceutical - 아시아경제

LG Chem Introduces Endometriosis Treatment 'Dinagest' from Japan's Mochida Pharmaceutical 아시아경제

Published: April 2, 2026, 11:40 p.m.
Global epidemiology of ovarian cancer: patterns, trends, and risk factors.

Ovarian cancer was the eighth most frequently diagnosed cancer among women in 2022. The global age-standardized incidence rate of ovarian cancer decreased from 7.22/100,000 to 6.71/100,000 from 1990 to 2021. …

Published: March 24, 2026, midnight
Kissei Pharmaceutical Aktie surges on Icelty launch for uterine fibroids in Japan - AD HOC NEWS

Kissei Pharmaceutical Aktie surges on Icelty launch for uterine fibroids in Japan AD HOC NEWS

Published: March 20, 2026, 5:40 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!